Patents by Inventor Vanagamudi Subramaniam Sulur

Vanagamudi Subramaniam Sulur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120142631
    Abstract: The present invention is directed to a composition for treating diaper rashes, along with skin rejuvenation containing a) a biopolymer in the form of Chitosan, b) a combination of active pharmaceutical ingredients (APIs), Benzalkonium Chloride & Cetrimide used in treating diaper rashes, c) a cream base containing primary and secondary emulsifiers, waxy materials, co-solvents, acids, preservatives, buffering agents, anti oxidants, chelating agents, and humectants, and d) water. The active ingredients, namely chitosan, Benzalkonium Chloride & Cetrimide are incorporated in cream base for use in treating diaper rashes due to allergy & itching, & wounds on human skin involving contacting human skin with the above identified composition.
    Type: Application
    Filed: April 20, 2010
    Publication date: June 7, 2012
    Applicant: APEX LABORATORIES PRIVATE LIMITED
    Inventors: Vanagamudi Subramaniam Sulur, Madhavan Srinivasan, Neelakandan Narayanan Chulliel, Kausik Ghosh, Haridas Sankar
  • Publication number: 20120115828
    Abstract: The present invention is directed to a composition for treating bacterial skin infections & skin inflammation, along with skin rejuvenation. More particularly, the present invention relates to a pharmaceutical cream comprising a biopolymer, a corticosteroid and an antibacterial active ingredient. It discloses a composition for treating fungal skin infections & skin inflammation, along with skin rejuvenation containing a) a biopolymer in the form of chitosan, b) a combination of active pharmaceutical ingredients (APIs), miconazole and hydrocortisone acetate used in treating bacterial skin infections & skin inflammations, c) a cream base containing primary and secondary emulsifiers, waxy materials, co-solvents, acids, preservatives, buffering agents, anti oxidants, chelating agents, and humectants and d) water.
    Type: Application
    Filed: April 14, 2010
    Publication date: May 10, 2012
    Applicant: APEX LABORATORIES PRIVATE LIMITED
    Inventors: Vanagamudi Subramaniam Sulur, Madhavan Srinivasan, Neelakandan Narayanan Chulliel, Balkrishnana Selvaraj
  • Publication number: 20120040927
    Abstract: The present invention is directed to a composition for treating fungal skin infections & skin inflammation, along with skin rejuvenation. More particularly, the present invention relates to a pharmaceutical cream comprising a biopolymer, a corticosteroid and an antifungal active ingredient. It discloses a composition for treating fungal skin infections & skin inflammation, along with skin rejuvenation containing a) a biopolymer in the form of chitosan, b) a combination of active pharmaceutical ingredients (APIs), clotrimazole and hydrocortisone acetate used in treating fungal skin infections & skin inflammations, c) a cream base containing primary and secondary emulsifiers, waxy materials, co-solvents, acids, preservatives, buffering agents, anti oxidants, chelating agents, and humectants and d) water.
    Type: Application
    Filed: April 14, 2010
    Publication date: February 16, 2012
    Applicant: APEX LABORATORIES PRIVATE LIMITED
    Inventors: Vanagamudi Subramaniam Sulur, Madhavan Srinivasan, Neelakandan Narayanan Chulliel, Balkrishnana Selvaraj, Haridas Sankar
  • Publication number: 20120035144
    Abstract: The present invention is directed to a medicinal composition for treating skin inflammations, fungal/bacterial skin infections and related wounds, and also other skin wounds including those caused by burns. The cream also causes skin rejuvenation through an epithelisation process. The cream comprises: a) a biopolymer in the form of Chitosan, b) active Pharmaceutical Ingredients (APIs), in the form of fusidic acid that has been generated in situ from sodium fusidate Hydrocortisone acetate & clotrimazole, c) a cream base containing primary and secondary emulsifiers, waxy materials, co-solvents, acids, preservatives, buffering agents, anti oxidants, chelating agents, and humectants and d) water. The invention also discloses a process to make medicinal cream containing Fusidic acid formed in situ from Sodium Fusidate by converting it into Fusidic acid under oxygen-free environment. The cream has greater shelf-life and the finer particle size of the API than the conventional creams containing Fusidic acid.
    Type: Application
    Filed: April 20, 2010
    Publication date: February 9, 2012
    Applicant: APEX LABORATORIES PRIVATE LIMITED
    Inventors: Vanagamudi Subramaniam Sulur, Madhavan Srinivasan, Neelakandan Narayanan Chulliel, Balkrishnana Selvaraj, Haridas Sankar
  • Publication number: 20110281831
    Abstract: The invention discloses a dermaceutical cream containing antifungal agents, steroids and an antibacterial agent in the form of Fusidic acid, which Fusidic acid is formed in situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate is converted into Fusidic acid under oxygen-free environment. The cream of the present invention has greater shelf-life stability and the finer particle size of the API than the conventional creams containing Fusidic acid. The cream of the present invention contains Fusidic acid as the API that has been formed in situ from Sodium Fusidate, and steroids in a cream base comprising an acid, a co-solvent, an emulsifier and a waxy material along with water, preferably purified water.
    Type: Application
    Filed: January 20, 2010
    Publication date: November 17, 2011
    Applicant: APEX LABORATORIES PRIVATE LIMITED
    Inventors: Vanagamudi Subramaniam Sulur, Madhavan Srinivasan, Neelakandan Narayanan Chulliel, Haridas Sankar, Balkrishnana Selvaraj